Talk to Sam
+1 917 267 7886
Search inside this page
Publication dates
data types
Free Market Research Guides to Download
» Download Public Reports
1-30 of about 200 reports
... Of imugene platform linguet Is a proprietary drug delivery technology that improves the efficacy and safety of a diverse number of prescription and over the counter medicines. The platform technology ...
... Product cands, and the timing and amount of any available investment tax credits, the actual or perceived benefits to users of our drug delivery technologies and product cands as compared ...
... Upon collaborative agreements with pharmaceutical and biotechnology companies to develop, test, obtain regulatory approval for and commercialize products that incorporate our drug delivery technologies ...
... Flml) business model is to blend high-value internally developed products with its leading drug delivery capabilities. The company has a proprietary pipeline of niche specialty pharmaceutical products ...
... Such as the eye. These high-precision drug delivery platforms are now being pursued by multiple interested parties. A71 the rita Disposable auto-injectors and lisa Reusable auto-injectors were supplied ...
... Rheumatoid arthritis and psoriasis, as well as vibex Qs t for testosterone replacement therapy. The company's technology platforms include vibex Disposable medi-jet , Disposable multi-use pen injectors ...
... Oral drug delivery technology seeks to deliver drugs orally to systemic circulation and cobacyte to diseased cells. The main use of the coboral technology will be to deliver drugs orally that otherwise could ...
... Promoting better compliance and improvement in dose accuracy. Several manufactus of injectable products have introduced convenient alternatives to vials, such as prefilled syringes and injector systems ...
... Manufacturing and commercialization of unique gelatin-based dosage forms. Banner has developed several patent-pending drug delivery platforms, including those that enhance and control the absorption of poorly ...
... On the development of novel, orally administered drug delivery products based on our proprietary oral drug delivery technologies. We have positioned ourselves as a provider of product development services ...
... delivery system technology. In accordance with the accounting standard for discontinued operations, the results of operations relating to both the visudyne business and the punctal plug drug delivery system ...
... Rescula eye drops 657 672 97.7% 1,933 34.0% Amitiza capsules 1,080 1,094 98.7% 2,331 46.4% R&d support services 94 104 91.1% 168 56.5% Operating income 306 325 94.4% 618 49.6% Ordinary ...
... About a.P. Pharma a.P. Pharma is a specialty pharmaceutical company developing products using its proprietary biochronomer polymer-based drug delivery platform. This drug delivery platform is designed ...
... In livingston, new jersey, milestone scientific is engaged in pioneering advanced computer-controlled drug delivery technologies for the medical and dental markets and currently sells its award-winning products ...
... Capabilities, frequently licensed to other pharmaceutical partners. Flamel S business is principally based on our legacy platform, including our drug delivery technologies and internal research and development ...
... To develop, manufacture and commercialize products using emisphere's drug delivery technology, emisphere's ability to fund such efforts with or without partners, and other risks and uncertainties detailed ...
... The appetite sensation, all of which are added positive characteristics that increase the value of a caffeine drug delivery system in the form of chewing gum.This eventually can lead to the development of a new ...
... For retinitis pigmentosa patients who cannot use eye drops frequently. In addition to sucampo S acquisition of approval to sell and manufacture amitza capsule as a treatment for chronic constipation within ...
... We granted to battelle the exclusive right to co-market our dosepro drug delivery technology to a specified list of battelle S pharmaceutical clients. We acquired the dosepro technology and related ...
... With the increasing trend toward self-injec- tion and home administration of drugs, there is a growing need for drug delivery devices that can deliver higher volumes of drugs subcutane- ously. Innovations ...
... Proof operation of a simple mechanically-driven device is easily adoptable; proof of value yet to be demonstrated addressable market size 5 pulmonary drug deliveries are worth tens of billions u.S. Dollars ...
... About phosphagenics phosphagenics is commercialising drug delivery applications based on its novel transdermal (drugs administered via skin) tpm Targeted penetration matrix technology. Tpm ...
... Opportunities v ib ro ve in tm Disposable Acute Home Sampling Triage Pathology Blood banking Surgical Sclerotherapy Bre at he assi st tm Sport performance drug delivery Snoring reduction ...
... Of the device market, with an estimated of cagr of 17.5% To 2016 (global injectable drug delivery market 2010; marketsandmarkets). Trional auto-injector devices are relatively large in size, as they must ...
... Or perceived benefits to users of our drug delivery technologies and product cands as compared to others, our ability to maintain and establish intellectual property rights in our drug delivery ...
... Temperature data in a product/container format that is the same as typically used during laboratory and manufacturing scale freeze drying (a vial). Project goal Compare oct-fdm measurement technique ...
» Purchase Premium Reports (From $ 125 - $ 2 995)
About 200 reports
The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading ...
Reportlinker.com © Copyright 2013. All rights reserved.